Here's a round-up of companies in the S&P/ASX 200 Index (ASX: XJO) turning ex-dividend next week.
The ex-dividend date is the cut-off to determine which investors are eligible for a company's upcoming dividend payment.
If you buy shares on or after the ex-dividend date, you won't be able to bag the upcoming payment. Instead, the dividend will remain with the seller on the other side of the transaction.
However, a company's shares typically drop on the day they turn ex-dividend as the value of the dividend payment leaves the share price.
Without further ado, let's take a look at the trio of ASX 200 shares going ex-dividend next week.
Collins Foods Ltd (ASX: CKF)
First up, shares in fast food franchisee Collins Foods will be trading ex-dividend on Monday.
This means that today will be the last day to lock in the company's latest fully franked dividend of 12 cents per share.
Investors on Collins Foods' share registry by the closing bell today can pencil in a payment date of 29 December.
Alternatively, the ASX 200 share has a dividend reinvestment plan (DRP) available. Shareholders will have until Wednesday, 7 December to elect to participate in the DRP.
Collins Foods handed in its first-half FY23 results earlier this week, much to the dismay of the market.
The Collins Foods share price ended the day 20% lower as investors digested a set of results impacted by cost inflation.
The company delivered 15% top-line growth, with revenue coming in at $614 million. But inflation and wage increases squeezed Collins Foods' earnings margins.
Earnings before interest, tax, depreciation, and amortisation (EBITDA) climbed by just 1% to $93.4 million. Meanwhile, net profit after tax (NPAT) slumped 58% to $11 million, weighed down by an $11.9 million non-cash impairment of eight Taco Bell restaurants.
Nonetheless, Collins Foods kept its interim dividend steady at 12 cents per share. This puts Collins Foods shares on a trailing 12-month dividend yield of 3.5%. Throwing in the benefit of franking credits dials up this yield to 4.9%.
Incitec Pivot Ltd (ASX: IPL)
Like Collins Foods, Incitec Pivot is another ASX 200 share turning ex-dividend on Monday.
Today will be the last day that Incitec Pivot shares will trade with rights to the company's FY22 final dividend of 17 cents per share.
This fully franked dividend is set to land in shareholders' bank accounts on 21 December.
Last month, the explosives and fertilisers company released its full-year results. FY22 was a bumper year for Incitec Pivot, underpinned by volume growth and higher prices.
Revenue jumped by 45% to $6.3 billion, while normalised NPAT rocketed by 186% to $1.0 billion.
This tremendous growth allowed the company to more than triple its annual dividends to 27 cents, fully franked. This is on top of a $400 million on-market share buyback that will be conducted over the next 12 months.
Based on current prices, Incitec Pivot shares are spinning up an eye-catching trailing dividend yield of 6.8%. Including franking credits, this yield cranks up to 9.6%.
The company is still planning to separate its fertilisers and explosives businesses to create two separately-listed companies on the ASX.
Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)
Rounding out this trio of ASX 200 shares going ex-dividend next week is Fisher & Paykel, the dual-listed ASX healthcare share.
Fisher & Paykel shares will be turning ex-dividend on Thursday, trading without claims to the company's latest unfranked interim dividend of 17.5 NZ cents.
As part of a Kiwi tax regime, the company will also be paying a supplementary dividend of roughly 3 NZ cents per share to shareholders who aren't New Zealand residents.
Fisher & Paykel has locked in a payment date of 21 December. Alternatively, the company has reactivated its DRP for shareholders residing in New Zealand, Australia, and the UK. These shareholders will have until 12 December to opt in. Those who do will receive a 3% discount for their troubles.
Earlier this week, Fisher & Paykel posted its first-half FY23 results. These results were headlined by total operating revenue of NZ$690.6 million, which came in ahead of guidance of NZ$670 million.
Despite beating guidance, revenue was down 23% compared to the prior corresponding period as the company lapped significant COVID-driven demand.
However, it's settled on a higher base, with revenue sitting 21% above the comparable pre-pandemic period.
Profits took an even bigger tumble but Fisher & Paykel still increased its interim dividend by 3% to 17.5 NZ cents.
At current levels, Fisher & Paykel shares are flashing a trailing 12-month dividend yield of around 1.9%.
